Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guohong Han

Showing results (111-120 of 200) with videos related to

Pageof 20
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2015
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort studyXingshun Qi, Chuangye He, Wengang Guo, et al.
Journal of Gastroenterology and Hepatology|November 3, 2019
Long-term results of variceal bleeding management in 302 patients with chronic extrahepatic portal vein obstructionHui Chen, Chuangye He, Yong Lv, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2013
Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centreXingshun Qi, Wengang Guo, Chuangye He, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 18, 2013
Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosisLei Liu, Yan Zhao, Xingshun Qi, et al.
Nanomedicine (London, England)|June 18, 2015
Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translationKangan Li, Andrew C Gordon, Linfeng Zheng, et al.
Frontiers in Medicine|June 28, 2021
Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19Yong Lv, Xiaodi Zhao, Yan Wang, et al.
Theranostics|June 3, 2014
The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE)Wenhui Ma, Jia Jia, Shengjun Wang, et al.
International Journal of Cancer|August 8, 2014
The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trialYee Chao, Young-Hwa Chung, Guohong Han, et al.
International Journal of Nanomedicine|September 17, 2013
Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticlesYang Guo, Zhuoli Zhang, Dong-Hyun Kim, et al.
International Journal of Cancer|November 7, 2012
Interim analysis of START: Study in Asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trialYoung-Hwa Chung, Guohong Han, Jung-Hwan Yoon, et al.
Pageof 20

Showing results (111-120 of 200) with videos related to

Sort By:
Pageof 20
Liver International : Official Journal of the International Association for the Study of the Liver|August 4, 2015
Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort studyXingshun Qi, Chuangye He, Wengang Guo, et al.
Journal of Gastroenterology and Hepatology|November 3, 2019
Long-term results of variceal bleeding management in 302 patients with chronic extrahepatic portal vein obstructionHui Chen, Chuangye He, Yong Lv, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2013
Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: techniques, indications and results on 51 Chinese patients from a single centreXingshun Qi, Wengang Guo, Chuangye He, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 18, 2013
Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosisLei Liu, Yan Zhao, Xingshun Qi, et al.
Nanomedicine (London, England)|June 18, 2015
Clinically applicable magnetic-labeling of natural killer cells for MRI of transcatheter delivery to liver tumors: preclinical validation for clinical translationKangan Li, Andrew C Gordon, Linfeng Zheng, et al.
Frontiers in Medicine|June 28, 2021
Abnormal Liver Function Tests Were Associated With Adverse Clinical Outcomes: An Observational Cohort Study of 2,912 Patients With COVID-19Yong Lv, Xiaodi Zhao, Yan Wang, et al.
Theranostics|June 3, 2014
The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE)Wenhui Ma, Jia Jia, Shengjun Wang, et al.
International Journal of Cancer|August 8, 2014
The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: final results of the START trialYee Chao, Young-Hwa Chung, Guohong Han, et al.
International Journal of Nanomedicine|September 17, 2013
Photothermal ablation of pancreatic cancer cells with hybrid iron-oxide core gold-shell nanoparticlesYang Guo, Zhuoli Zhang, Dong-Hyun Kim, et al.
International Journal of Cancer|November 7, 2012
Interim analysis of START: Study in Asia of the combination of TACE (transcatheter arterial chemoembolization) with sorafenib in patients with hepatocellular carcinoma trialYoung-Hwa Chung, Guohong Han, Jung-Hwan Yoon, et al.
Pageof 20